{"id":412338,"date":"2021-01-11T13:55:46","date_gmt":"2021-01-11T18:55:46","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=412338"},"modified":"2021-01-11T13:55:46","modified_gmt":"2021-01-11T18:55:46","slug":"allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/","title":{"rendered":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience"},"content":{"rendered":"

<\/p>\n

AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience<\/b><\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE<\/a>)–
\nAlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation & Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) taking place virtually February 8 \u2013 12, 2021.\n<\/p>\n

\nDetails of the oral presentations are as follows:\n<\/p>\n

Presentation Title:<\/b>Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Pediatric and Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
\n<\/a>
Presenter<\/b>: Joseph P. McGuirk, DO, The University of Kansas Cancer Center
\n
Assigned session:<\/b> Oral Abstract – Session C – Health Services
\n
Session Date & Time: <\/b>Monday, February 8, 2021, 2:30 p.m. CST
\n
Presentation Tine: <\/b>2:30 \u2013 2:45 p.m. CST
\n
Abstract Number<\/b>: 19\n<\/p>\n

Presentation Title: <\/b>Economic Burden and Health Resource Utilization Associated with dsDNA Virus Infections in Allogeneic Hematopoietic Cell Transplantation Recipients<\/span><\/a>
<\/span>Presenter<\/b>: Richard Maziarz, MD, Knight Cancer Institute, Oregon Health and Science University
\n
Assigned session<\/b>: Oral Abstract – Session C – Health Services
\n
Session Date & Time: <\/b>Monday, February 8, 2021, 2:30 p.m. CST
\n
Presentation Time: <\/b>3:15 \u2013 3:30 p.m. CST
\n
Abstract Number<\/b>: 22\n<\/p>\n

Presentation Title:<\/b>Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Lymphocytes for the Treatment of Virus-Associated Hemorrhagic Cystitis in the Post-HSCT Setting
\n<\/a>
Presenter<\/b>: Thomas Pfeiffer, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, Houston Methodist Hospital, Houston, TX
\n
Assigned session<\/b>: Oral Abstract – Session M – Infection and Immunity
\n
Session Date & Time<\/b>: Thursday, February 11, 2021, 3:00 p.m. CST
\n
Presentation Time: <\/b>4:45 \u2013 5:00 p.m. CST
\n
Abstract Number<\/b>: 95\n<\/p>\n

\nDetails of the poster presentations are as follows:\n<\/p>\n

Presentation Title<\/b>: Allogeneic, Off-the-Shelf, Sars-CoV-2-Specific T Cells to Treat High-Risk Patients with COVID-19
\n<\/a>
Presenter: <\/b>Spyridoula Vasileiou, Ph.D., Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children\u2019s Hospital and The Methodist Hospital
\n
Poster number<\/b>: 422\n<\/p>\n

About AlloVir<\/b><\/p>\n

\nAlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with weakened immune systems. The company\u2019s innovative and proprietary technology platform leverages off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir\u2019s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio. For more information visit www.allovir.com<\/a>.\n<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding AlloVir\u2019s development and regulatory status of our product candidates and its strategy, business plans and focus. The words \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d \u201ctarget\u201d and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management\u2019s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those related to AlloVir\u2019s financial results, the timing for completion of AlloVir\u2019s clinical trials of its product candidates, whether and when, if at all, AlloVir\u2019s product candidates will receive approval from the U.S. Food and Drug Administration, or FDA, or other foreign regulatory authorities, competition from other biopharmaceutical companies, and other risks identified in AlloVir\u2019s SEC filings. AlloVir cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. AlloVir disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent AlloVir\u2019s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210111005938\/en\/<\/a><\/span><\/p>\n

Media contact:
\n<\/b>
Courtney Heath
\n
ScientPR
\n
AlloVirPR@scientpr.com
\n<\/a>
617-872-2462\n<\/p>\n

Investor contact:
\n<\/b>
Medha Chadha
\n
AlloVir
\n
ir@allovir.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Oncology Health Infectious Diseases Hospitals Clinical Trials Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience CAMBRIDGE, Mass.–(BUSINESS WIRE)– AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation & Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) taking place virtually February 8 \u2013 12, 2021. Details of the oral presentations are as follows: Presentation Title:Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Pediatric and Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Presenter: Joseph P. McGuirk, DO, The University of Kansas Cancer Center Assigned session: Oral Abstract – Session C … <\/p>\n

Continue reading “AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-412338","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience CAMBRIDGE, Mass.–(BUSINESS WIRE)– AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation & Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) taking place virtually February 8 \u2013 12, 2021. Details of the oral presentations are as follows: Presentation Title:Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Pediatric and Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Presenter: Joseph P. McGuirk, DO, The University of Kansas Cancer Center Assigned session: Oral Abstract – Session C … Continue reading "AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-11T18:55:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience\",\"datePublished\":\"2021-01-11T18:55:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/\"},\"wordCount\":784,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/\",\"name\":\"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-11T18:55:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/","og_locale":"en_US","og_type":"article","og_title":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Market Newsdesk","og_description":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience CAMBRIDGE, Mass.–(BUSINESS WIRE)– AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation & Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) taking place virtually February 8 \u2013 12, 2021. Details of the oral presentations are as follows: Presentation Title:Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Pediatric and Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Presenter: Joseph P. McGuirk, DO, The University of Kansas Cancer Center Assigned session: Oral Abstract – Session C … Continue reading \"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-11T18:55:46+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience","datePublished":"2021-01-11T18:55:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/"},"wordCount":784,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/","name":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-11T18:55:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210111005938r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allovir-announces-data-presentations-at-the-2021-transplantation-cellular-therapy-meeting-digital-experience\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/412338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=412338"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/412338\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=412338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=412338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=412338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}